Deal Snapshot
Eagle Pharmaceuticals Takes Equity Stake in Enalare Therapeutics
Friday 12 August 2022

US-based Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX) has inked an agreement to make an equity investment of USD 25m in clinical-stage privately held biopharmaceutical company Enalare Therapeutics Inc, the company said.

Enalare is focused on developing novel therapies for patients suffering from life-threatening acute respiratory and critical care conditions.

Date Published: 12/08/2022